 Immunoglobulins, Intravenous
"Immunoglobulins, Intravenous" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Immunoglobulin preparations used in intravenous infusion, containing primarily IMMUNOGLOBULIN G. They are used to treat a variety of diseases associated with decreased or abnormal immunoglobulin levels including pediatric AIDS; primary HYPERGAMMAGLOBULINEMIA; SCID; CYTOMEGALOVIRUS infections in transplant recipients, LYMPHOCYTIC LEUKEMIA, CHRONIC; Kawasaki syndrome, infection in neonates, and IDIOPATHIC THROMBOCYTOPENIC PURPURA.
| Descriptor ID |
D016756
|
| MeSH Number(s) |
D12.776.124.486.485.114.619.393.536 D12.776.124.486.485.114.632 D12.776.124.790.651.114.632 D12.776.377.715.548.114.632
|
| Concept/Terms |
Immunoglobulins, Intravenous- Immunoglobulins, Intravenous
- Immune Globulin, Intravenous
- Intravenous Immune Globulin
- Intravenous Antibodies
- Intravenous Immunoglobulins
- IV Immunoglobulins
- Immunoglobulins, IV
- IVIG
- Antibodies, Intravenous
- Intravenous IG
Flebogamma DIF- Flebogamma DIF
- Grifols Brand of Intravenous Immunoglobulins, Human
Gammagard- Gammagard
- Iveegam
- Baxter Brand of Intravenous Immunoglobulins, Human
Gammonativ- Gammonativ
- Octapharma Brand of Intravenous Immunoglobulins, Human
Gamunex- Gamunex
- Bayer Brand of Intravenous Immunoglobulins, Human
Intraglobin F- Intraglobin F
- Biotest Brand of Intravenous Immunoglobulins, Human
Intravenous Immunoglobulins, Human- Intravenous Immunoglobulins, Human
- Human Intravenous Immunoglobulins
- Immunoglobulins, Human Intravenous
- Immunoglobulins, Intravenous, Human
- Immune Globulin Intravenous (Human)
Privigen- Privigen
- Venimmune
- CSL Behring Brand of Intravenous Immunoglobulins, Human
|
Below are MeSH descriptors whose meaning is more general than "Immunoglobulins, Intravenous".
Below are MeSH descriptors whose meaning is more specific than "Immunoglobulins, Intravenous".
This graph shows the total number of publications written about "Immunoglobulins, Intravenous" by people in this website by year, and whether "Immunoglobulins, Intravenous" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 1 | 0 | 1 | | 2002 | 0 | 1 | 1 | | 2003 | 0 | 1 | 1 | | 2006 | 0 | 1 | 1 | | 2007 | 1 | 0 | 1 | | 2009 | 1 | 0 | 1 | | 2010 | 0 | 1 | 1 | | 2014 | 0 | 3 | 3 | | 2016 | 0 | 1 | 1 | | 2017 | 2 | 2 | 4 | | 2018 | 2 | 1 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Immunoglobulins, Intravenous" by people in Profiles.
-
Ochs HD, Melamed I, Borte M, Moy JN, Pyringer B, D Kobayashi AL, Knutsen AP, Smits W, Pituch-Noworolska A, Kobayashi RH. Intravenous immunoglobulin 10% in children with primary immunodeficiency diseases. Immunotherapy. 2018 10; 10(14):1193-1202.
-
Antoon JW, Goldman JL, Shah SS, Lee B. A Retrospective Cohort Study of the Management and Outcomes of Children Hospitalized with Stevens-Johnson Syndrome or Toxic Epidermal Necrolysis. J Allergy Clin Immunol Pract. 2019 01; 7(1):244-250.e1.
-
Melamed IR, Borte M, Trawnicek L, Kobayashi AL, Kobayashi RH, Knutsen A, Gupta S, Smits W, Pituch-Noworolska A, Strach M, Pulka G, Ochs HD, Moy JN. Pharmacokinetics of a novel human intravenous immunoglobulin 10% in patients with primary immunodeficiency diseases: Analysis of a phase III, multicentre, prospective, open-label study. Eur J Pharm Sci. 2018 Jun 15; 118:80-86.
-
Schneider JR, Carias AM, Bastian AR, Cianci GC, Kiser PF, Veazey RS, Hope TJ. Long-term direct visualization of passively transferred fluorophore-conjugated antibodies. J Immunol Methods. 2017 11; 450:66-72.
-
Palau J, Sancho E, Herrera M, Sánchez S, Mingot ME, Upegui RI, Rodríguez Salazar MJ, de la Cruz F, Fernández MC, González López TJ, Hernández JJ, Ríos E, López-Fernández MF, García M, Hernández JÁ, Sanz MA. Characteristics and management of primary and other immune thrombocytopenias: Spanish registry study. Hematology. 2017 Sep; 22(8):484-492.
-
Wasserman RL, Melamed IR, Stein MR, Jolles S, Norton M, Moy JN. Evaluation of the Safety, Tolerability, and Pharmacokinetics of Gammaplex® 10% Versus Gammaplex® 5% in Subjects with Primary Immunodeficiency. J Clin Immunol. 2017 Apr; 37(3):301-310.
-
Kizilbash S, Claes D, Ashoor I, Chen A, Jandeska S, Matar RB, Misurac J, Sherbotie J, Twombley K, Verghese P. Bortezomib in the treatment of antibody-mediated rejection in pediatric kidney transplant recipients: A multicenter Midwest Pediatric Nephrology Consortium study. Pediatr Transplant. 2017 May; 21(3).
-
Soleimani-Meigooni DN, Schwetye KE, Angeles MR, Ryschkewitsch CF, Major EO, Dang X, Koralnik IJ, Schmidt RE, Clifford DB, Kuhlmann FM, Bucelli RC. JC virus granule cell neuronopathy in the setting of chronic lymphopenia treated with recombinant interleukin-7. J Neurovirol. 2017 02; 23(1):141-146.
-
Makatsori M, Kiani-Alikhan S, Manson AL, Verma N, Leandro M, Gurugama NP, Longhurst HJ, Grigoriadou S, Buckland M, Kanfer E, Hanson S, Ibrahim MA, Grimbacher B, Chee R, Seneviratne SL. Hypogammaglobulinaemia after rituximab treatment-incidence and outcomes. QJM. 2014 Oct; 107(10):821-8.
-
Hadley I, Jain R, Sreih A. Nonvasculitic autoimmune meningoencephalitis after rituximab: the potential downside of depleting regulatory B cells in the brain. J Clin Rheumatol. 2014 Apr; 20(3):163-6.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|